Summit Global Investments’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,441
Closed -$327K 556
2023
Q4
$327K Sell
1,441
-103
-7% -$21.6K 0.02% 413
2023
Q3
$310K Sell
1,544
-6,265
-80% -$1.32M 0.02% 419
2023
Q2
$1.62M Sell
7,809
-41
-0.5% -$7.95K 0.11% 151
2023
Q1
$1.55M Buy
7,850
+142
+2% +$29.2K 0.12% 160
2022
Q4
$1.56M Sell
7,708
-106
-1% -$20.7K 0.13% 159
2022
Q3
$1.38M Sell
7,814
-41
-0.5% -$8.39K 0.13% 166
2022
Q2
$1.58M Buy
7,855
+141
+2% +$30.1K 0.14% 158
2022
Q1
$1.75M Buy
+7,714
New +$1.81M 0.13% 164
2018
Q2
Sell
-49,556
Closed -$6.89M 290
2018
Q1
$6.89M Sell
49,556
-13,895
-22% -$2.04M 1.1% 31
2017
Q4
$8.7M Sell
63,451
-41,276
-39% -$5.45M 1.35% 26
2017
Q3
$13.6M Buy
104,727
+55,532
+113% +$7.41M 2.12% 7
2017
Q2
$6.51M Buy
49,195
+37,716
+329% +$4.62M 1.95% 5
2017
Q1
$1.41M Buy
11,479
+4,391
+62% +$520K 0.46% 60
2016
Q4
$782K Buy
+7,088
New +$787K 0.28% 77

Other funds holding LH

Summit Global Investments's LH Position: Q1 2024 in Review

Summit Global Investments sold out of Labcorp (LH) in Q1 2024, closing a stake of 1,441 shares — an estimated $327K sold.

Summit Global Investments first reported a position in LH in Q4 2016 and held it in 14 quarters. The position peaked at $13.6M in Q3 2017. 928 funds tracked by Wall St. Rank hold LH as of Q1 2024.

  • Summit Global Investments reported no remaining Labcorp position as of Q1 2024 after selling out during the quarter.
  • Summit Global Investments sold 1,441 Labcorp shares in Q1 2024, an estimated $327K.
  • Summit Global Investments first reported a position in Labcorp in Q4 2016 and held it in 14 quarters.
  • Summit Global Investments's Labcorp position peaked at $13.6M in Q3 2017.
  • 928 funds tracked by Wall St. Rank held Labcorp as of Q1 2024.

Based on Summit Global Investments's 13F filing for Q1 2024, filed 29 Apr 2024.